bufalin and betadex
bufalin has been researched along with betadex in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Che, X; Liu, Y; Ma, Y; Qu, X; Teng, Y; Xu, L; Yan, S; Zhang, L; Zou, H | 1 |
| Garamus, VM; Handge, UA; Willumeit-Römer, R; Yin, P; Zhao, X; Zou, A | 1 |
Other Studies
2 other study(ies) available for bufalin and betadex
| Article | Year |
|---|---|
Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Breast Neoplasms; Bufanolides; Cell Line, Tumor; Cholesterol; Female; Humans; Membrane Microdomains; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand | 2014 |
Folate receptor targeted bufalin/β-cyclodextrin supramolecular inclusion complex for enhanced solubility and anti-tumor efficiency of bufalin.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Bufanolides; Calorimetry, Differential Scanning; Folic Acid; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2017 |